浅析药物研发外包过程中的风险因素 |
| |
引用本文: | 张翀,邱家学.浅析药物研发外包过程中的风险因素[J].中国药物经济学,2010(2):37-41. |
| |
作者姓名: | 张翀 邱家学 |
| |
作者单位: | 中国药科大学国际医药商学院,210009 |
| |
摘 要: | CRO由20世纪70年代诞生以来,经过20多年的迅猛发展,已经在药物研发领域替代了传统的学术角色。然而当前的制药企业普遍缺乏对药物研发外包行为风险的认识及评估。本文借鉴Bahli的理论,对药物研发外包行为的风险因素做出详尽的分析,以期丰富对药物研发外包行为的风险管理理论。
|
关 键 词: | CRO 风险因素 |
An Analysis of Risk Factors of Pharmaceutical R&D Outsourcing |
| |
Abstract: | Once come into being from 70 years of twenty century CRO had already substituted the position of traditional academic though a rapid development for 20 years.However,the risks for Pharmaceutical R&D Outsourcing were rarely mentioned. Drawing on the experience of Bahli's work,this article has analyze the risk factors of Pharmaceutical R&D Outsourcing,as to enrich the risk management theory for Pharmaceutical R&D Outsourcing. |
| |
Keywords: | CRO Risk Factors |
本文献已被 CNKI 维普 万方数据 等数据库收录! |
|